BlackRock’s HTG Molecular Diagnostics, Inc. Common Stock HTGM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-1,289
Closed -$3.48K 5593
2023
Q1
$3.48K Sell
1,289
-4,815
-79% -$13K ﹤0.01% 5322
2022
Q4
$24.4K Sell
6,104
-79
-1% -$315 ﹤0.01% 5269
2022
Q3
$45K Sell
6,183
-143
-2% -$1.04K ﹤0.01% 5292
2022
Q2
$78K Buy
6,326
+5,008
+380% +$61.7K ﹤0.01% 5217
2022
Q1
$22K Hold
1,318
﹤0.01% 5470
2021
Q4
$85K Buy
1,318
+24
+2% +$1.55K ﹤0.01% 5243
2021
Q3
$89K Hold
1,294
﹤0.01% 5103
2021
Q2
$91K Sell
1,294
-311
-19% -$21.9K ﹤0.01% 5007
2021
Q1
$105K Hold
1,605
﹤0.01% 4770
2020
Q4
$92K Buy
1,605
+1
+0.1% +$57 ﹤0.01% 4524
2020
Q3
$95K Sell
1,604
-2,047
-56% -$121K ﹤0.01% 4422
2020
Q2
$474K Buy
3,651
+1,052
+40% +$137K ﹤0.01% 4133
2020
Q1
$152K Buy
2,599
+345
+15% +$20.2K ﹤0.01% 4203
2019
Q4
$285K Buy
2,254
+20
+0.9% +$2.53K ﹤0.01% 4209
2019
Q3
$268K Sell
2,234
-21
-0.9% -$2.52K ﹤0.01% 4231
2019
Q2
$673K Buy
2,255
+1,882
+505% +$562K ﹤0.01% 4069
2019
Q1
$168K Sell
373
-119
-24% -$53.6K ﹤0.01% 4221
2018
Q4
$225K Buy
492
+69
+16% +$31.6K ﹤0.01% 4161
2018
Q3
$385K Buy
423
+17
+4% +$15.5K ﹤0.01% 4112
2018
Q2
$238K Buy
406
+310
+323% +$182K ﹤0.01% 4219
2018
Q1
$63K Buy
96
+34
+55% +$22.3K ﹤0.01% 4364
2017
Q4
$22K Buy
62
+3
+5% +$1.07K ﹤0.01% 4503
2017
Q3
$18K Hold
59
﹤0.01% 4553
2017
Q2
$29K Buy
59
+47
+392% +$23.1K ﹤0.01% 4534
2017
Q1
$15K Buy
+12
New +$15K ﹤0.01% 4597
2016
Q4
Sell
-22
Closed -$9K 3751
2016
Q3
$9K Sell
22
-2
-8% -$818 ﹤0.01% 3360
2016
Q2
$12K Sell
24
-9
-27% -$4.5K ﹤0.01% 3348
2016
Q1
$17K Sell
33
-5
-13% -$2.58K ﹤0.01% 2881
2015
Q4
$30K Hold
38
﹤0.01% 2336
2015
Q3
$53K Hold
38
﹤0.01% 1864
2015
Q2
$77K Buy
+38
New +$77K ﹤0.01% 1818